tiprankstipranks
Trending News
More News >
NextCell Pharma AB (DE:65G)
FRANKFURT:65G
Germany Market
Advertisement

NextCell Pharma AB (65G) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
NextCell Pharma AB’s (65G) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting NextCell Pharma AB is a Buy.
NextCell Pharma AB’s (65G) 20-Day exponential moving average is 0.09, while NextCell Pharma AB’s (65G) share price is <€0.1, making it a Buy.
NextCell Pharma AB’s (65G) 50-Day exponential moving average is 0.09, while NextCell Pharma AB’s (65G) share price is <€0.1, making it a Sell.

NextCell Pharma AB (65G) Pivot Points

Sep 07, 2025, 07:18 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.09
0.09
0.09
0.09
0.09
0.09
Fibonacci
0.09
0.09
0.09
0.09
0.09
0.09
0.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NextCell Pharma AB (65G) Moving Averages

Sep 07, 2025, 07:18 AM
Period
Simple
Exponential
MA5
0.09Sell
0.09Sell
MA10
0.09Sell
0.09Buy
MA20
0.09Sell
0.09Buy
MA50
0.09Buy
0.09Sell
MA100
0.08Buy
0.10Sell
MA200
0.14Sell
0.12Sell
NextCell Pharma AB’s (65G) 10-Day exponential moving average is 0.09, while NextCell Pharma AB’s (65G) share price is <€0.1, making it a Buy.
NextCell Pharma AB’s (65G) 100-Day exponential moving average is 0.10, while NextCell Pharma AB’s (65G) share price is <€0.1, making it a Sell.
NextCell Pharma AB’s (65G) stock price is <€0.1 and NextCell Pharma AB’s (65G) 50-day simple moving average is 0.09, creating a Buy signal.
NextCell Pharma AB’s (65G) stock price is <€0.1 and NextCell Pharma AB’s (65G) 100-day simple moving average is 0.08, creating a Buy signal.
NextCell Pharma AB’s (65G) stock price is <€0.1 and NextCell Pharma AB’s (65G) 200-day simple moving average is 0.14, creating a Sell signal.

NextCell Pharma AB (65G) Technical Indicators

Sep 07, 2025, 07:18 AM
Name
Value
Implied Action
RSI (14)
53.60
Neutral
STOCH (9,6)
60.00
Neutral
STOCHRSI (14)
60.00
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
8.12
Buy
Williams %R
-40.00
Buy
CCI (14)
-103.29
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
55.83
Neutral
ROC
0.00
Sell
NextCell Pharma AB’s (65G) Relative Strength Index (RSI) is 53.60, creating a Neutral signal.
NextCell Pharma AB’s (65G) Trend Strength Indicator (ADX) is 8.12, creating a Buy signal.
NextCell Pharma AB’s (65G) Commodity Channel Index (CCI) is -103.29, creating a Buy signal.

FAQ

Is 65G a Buy, Hold, or Sell?
Based on 65G’s technical indicators, 65G is a Hold.
    What is 65G’s RSI (14)?
    65G’s RSI (14) is 53.60, which suggests 65G is a Neutral.
      What is 65G’s MACD?
      65G’s MACD is <0.01, which suggests 65G is a Buy.
        What is 65G’s 5-day moving average?
        65G’s 5-day moving average is 0.09, which suggests 65G is a Sell.
          What is 65G’s 20-day moving average?
          65G 20-day moving average is 0.09, which suggests 65G is a Sell.
            What is 65G’s 50-day moving average?
            65G’s 50-day moving average is 0.09, which suggests 65G is a Buy.
              What is 65G’s 200-day moving average?
              65G’s 200-day moving average is 0.14, which suggests 65G is a Sell.
                What is 65G’s Williams % R (14)?
                65G’s Williams % R (14) is -40.00, which suggests 65G is a Buy.
                  What is 65G’s CCI (14)?
                  65G’s CCI (14) is -103.29, which suggests 65G is a Buy.
                    What is the share price of NextCell Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis